BEAMSTART Logo

HomeNews

Not all cancer patients need chemo. Ataraxis AI raised $20M to fix that.

TechCrunch LogoTechCrunch17h ago

Not all cancer patients need chemo. Ataraxis AI raised $20M to fix that. - TechCrunch

Quick Summary:

Not all cancer patients need chemo.

Ataraxis’ tech is powered by an AI model that extracts information from high-resolution images of cancer cells.

Artificial intelligence is a big trend in cancer care, and it’s mostly focused detecting cancer at the earliest possible stage.

More Pictures

Not all cancer patients need chemo. Ataraxis AI raised $20M to fix that. - TechCrunch (Picture 1)

or

Article Details

Author / Journalist: Charles Rollet

Category: Technology

Markets:

Topics:

Source Website Secure: Yes (HTTPS)

News Sentiment: Neutral

Fact Checked: Legitimate

Article Type: News Report

Published On: 2025-03-05 @ 18:54:39 (17 hours ago)

News Timezone: GMT -5:00

News Source URL: techcrunch.com

Language: English

Article Length: 562 words

Reading Time: 4 minutes read

Sentences: 25 lines

Sentence Length: 23 words per sentence (average)

Platforms: Desktop Web, Mobile Web, iOS App, Android App

Copyright Owner: © TechCrunch

News ID: 26683875

View Article Analysis

About TechCrunch

TechCrunch Logo

Main Topics: Technology

Official Website: techcrunch.com

Update Frequency: 38 posts per day

Year Established: 2005

Headquarters: United States

News Last Updated: 13 hours ago

Coverage Areas: United States

Ownership: Independent Company

Publication Timezone: GMT -5:00

Content Availability: Worldwide

News Language: English

RSS Feed: Available (XML)

API Access: Available (JSON, REST)

Website Security: Secure (HTTPS)

Publisher ID: #20

Publisher Details

Frequently Asked Questions

How long will it take to read this news story?

The story "Not all cancer patients need chemo. Ataraxis AI raised $20M to fix that." has 562 words across 25 sentences, which will take approximately 3 - 5 minutes for the average person to read.

Which news outlet covered this story?

The story "Not all cancer patients need chemo. Ataraxis AI raised $20M to fix that." was covered 17 hours ago by TechCrunch, a news publisher based in United States.

How trustworthy is 'TechCrunch' news outlet?

TechCrunch is a fully independent (privately-owned) news outlet established in 2005 that covers mostly technology news.

The outlet is headquartered in United States and publishes an average of 38 news stories per day.

It's most recent story was published 13 hours ago.

What do people currently think of this news story?

The sentiment for this story is currently Neutral, indicating that people are not responding positively or negatively to this news.

How do I report this news for inaccuracy?

You can report an inaccurate news publication to us via our contact page. Please also include the news #ID number and the URL to this story.
  • News ID: #26683875
  • URL: https://chronographically.beamstart.com/news/not-all-cancer-patients-need-17412009477789

BEAMSTART

BEAMSTART is a global entrepreneurship community, serving as a catalyst for innovation and collaboration. With a mission to empower entrepreneurs, we offer exclusive deals with savings totaling over $1,000,000, curated news, events, and a vast investor database. Through our portal, we aim to foster a supportive ecosystem where like-minded individuals can connect and create opportunities for growth and success.

Our Company

© Copyright 2025 BEAMSTART. All Rights Reserved.